Late-Breaking Clinical Trials Scheduled for Release at Heart Rhythm Society’s 34th Annual Scientific Sessions

Eighteen late-breaking clinical trials to be presented at Heart Rhythm 2013

May 09, 2013

Media Contact

Kennesha Baldwin
Heart Rhythm Society
media@hrsonline.org
202-464-3441

DENVER, May 9, 2013 – Late-Breaking Clinical Trials will be revealed at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.

Session I: Thursday, May 9, 2013, 10:30 a.m. – 12:00 p.m. MDT in Four Seasons Ballroom 3
Embargo Time: Thursday, May 9 at 9:00 a.m. MDT (time of press briefing)

  • Periprocedural Stroke And Bleeding Complications In Patients Undergoing Catheter Ablation Of Atrial Fibrillation With Different Anticoagulation Management: Results From The "COMPARE" Randomized Trial
  • Pacemaker And Defibrillator Surgery Without Interruption Of Oral Anticoagulation: Results Of The Bridge Or Continue Coumadin For Device Surgery Randomized Controlled Trial (Bruise Control)
  • Long Term Results Of Protect AF: The Mortality Effects Of Left Atrial Appendage Closure Versus Warfarin For Stroke Prophylaxis In AF
  • Delayed Enhancement Mri Determinant Of Successful Catheter Ablation For Atrial Fibrillation (decaaf): A Double-blinded, Multi-center, Prospective Trial
  • Treatment Of Paroxysmal Atrial Fibrillation By Targeted Elimination Of Stable Rotors And Focal Sources Without Pulmonary Vein Isolation: The Precise Rotor Elimination Without Concomitant Pulmonary Vein Isolation For Subsequent Elimination Of PAF (PRECISE) Trial
  • Optim ICD Lead Failures: Long-term Rates From An Independent Analysis Of >10,000 Leads In 3 Prospective Registries

Session II: Friday, May 10, 2013, 1:30 p.m. – 3:00 p.m. MDT in Four Seasons Ballroom 1
Embargo Time: Friday, May 19 at 11:30 a.m. MDT (time of press briefing)

  • Percutaneous In Vivo Placement Of A Novel Intracardiac Leadless Pacemaker: Results From The First-in-man Leadless Study
  • Eighteen Month Results From The Prospective Registry And Follow-up Of Patients Using The Lifevest Wearable Defibrillator (WEARIT-II Registry)
  • Ablation Of Symptomatic Paroxysmal Atrial Fibrillation Using Novel Contact Force Catheter: SMART-AF Trial
  • Progression of Atrial Fibrillation After A Failed Initial Ablation Procedure In Patients With Paroxysmal Atrial Fibrillation: A Randomized Comparison Of Antiarrhythmic Drug Therapy Vs Re-ablation
  • Clinical Significance Of Short AT/AF Episodes: Results From The Registry Of Atrial Tachycardia And Atrial Fibrillation Episodes In The Cardiac Rhythm Management Device Population (RATE)
  • Putting Evidence Into Practice: Shock Reduction Results From 4,131 Patients In The Prospective Shock-less Study

Session III: Saturday, May 11, 2013, 8:00 a.m. – 9:30 a.m. MDT in Mile High 4F
Embargo Time: Saturday, May 11 at 8:00 a.m. MDT

  • CITADEL/CENTURION Study Interim Analysis: Use Of An Antibacterial Envelope Is Associated With Very Low 90-day Cied Infection Rates
  • ICD Programming Trends And Relationship To Survival-the Altitude Dataset
  • Clinical Outcomes Are Improved With Biventricular Pacing Compared To Right Ventricular Pacing In Patients With Atrioventricular Block: An Analysis From The BLOCK HF Study
  • Evaluation Of Cardiac Implantable Electronic Device Infection Outcomes From A Large End Stage Renal Disease Database
  • Lower Occurrence Of Inappropriate Shock In Dual Chamber Icd Therapy Reached With Optimized Discrimination And Minimized Vp
  • Outcomes Of Catheter Ablation For Persistent/longstanding Persistent Atrial Fibrillation Are Significantly Improved By Targeting Rapid Focal Drivers

Press briefings featuring several Late-Breaking Clinical Trials will be held at 9:00 a.m. MDT on Thursday, May 9, and at 11:30 a.m. MDT on Friday, May 10. These briefings will be held in the Scientific Sessions’ press briefing room (Room 612) at the Colorado Convention Center.

More information on Late-Breaking Clinical Trials will be available at Heart Rhythm 2013.

Sessions details:
“Late-Breaking Clinical Trials Session I” [May 9, 2013, 10:30 a.m.–12:00 p.m. MDT, Four Seasons Ballroom 3]
“Late-Breaking Clinical Trials Session II” [May 10, 2013, 1:30 p.m. – 3:00 p.m. MDT, Four Seasons Ballroom 1]
“Late-Breaking Clinical Trials Session III” [May 11, 2013, 8:00 a.m.–9:30 a.m. MDT, Mile High 4F]

Heart Rhythm 2013 is the most comprehensive educational program for heart rhythm professionals, featuring more than 8,000 attendees, 250 educational sections and more than 130 exhibitors showcasing innovative products and services. The Heart Rhythm Society’s Annual Scientific Sessions have become the must-attend event of the year, allowing the exchange of new vital ideas and information among colleagues from every corner of the globe.

About the Heart Rhythm Society

The Heart Rhythm Society is the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education and optimal health care policies and standards. Incorporated in 1979 and based in Washington, DC, it has a membership of more than 5,800 heart rhythm professionals in more than 72 countries around the world. For more information, visit  www.HRSonline.org, voted 2012’s “Best in Class” website for a nonprofit by the Interactive Media Council.